IRE1β Inhibitors

IRE1β (also known as ERN2 or Inositol-Requiring Enzyme 1 beta) is an enzyme associated with the unfolded protein response (UPR) in the endoplasmic reticulum (ER), specifically involved in ER stress signaling pathways. This enzyme is homologous to IRE1α but exhibits distinct tissue expression patterns, being predominantly found in epithelial tissues such as the gastrointestinal tract. IRE1β inhibitors are chemical compounds that selectively inhibit the enzymatic activity of IRE1β, particularly its endoribonuclease (RNase) function. This inhibition interrupts the ER stress response pathways mediated by IRE1β, which is crucial for regulating protein homeostasis in epithelial cells under stress conditions.

These inhibitors typically target the kinase or RNase domains of IRE1β, depending on the mechanism of inhibition. By preventing IRE1β from cleaving specific mRNAs or from engaging in its signaling functions, these compounds can modulate downstream signaling events such as the attenuation of XBP1 mRNA splicing and other stress-responsive gene expression pathways. The chemical structures of these inhibitors vary widely, often including small molecules with selective binding affinities for the enzyme's active sites. Their mode of action can be highly specific, enabling the study of IRE1β's role in cellular processes like protein folding, degradation, and the maintenance of ER homeostasis. The precise inhibition of IRE1β allows for the detailed investigation of this enzyme's unique role within the UPR, separate from its more widely studied counterpart, IRE1α.